Skip to main content

Table 1 Model characteristics, population characteristics, costs and utilities

From: Economic evaluation of supplementing the diet with Souvenaid in patients with prodromal Alzheimer’s disease

  Source
Model characteristics
 Number of patients 100,000  
 Number of replications 1  
 Discount rate 3%  
 Cut-off for mild AD 4.5 [15]
 Cut-off for moderate AD 9.5 [15]
Population characteristics
 % male 0.46 [9]
 Age Mean (SD) 70.7 (6.2) [9]
 AgeCaregiver Mean (SD) 55.2 (14.5) [18]
 Site (%) 1, 2, 3, 4, 5 10, 10, 50, 10, 20 [14]
 Baseline MMSE score Mean (SD) 27.0 (5.3) [9]
Annual costs (mean)   [18]
 Souvenaid €1200  
 Diagnosis €2900 [19]
 Mild AD (health care) €3388  
 Mild AD (social care) €13,927  
 Mild AD (indirect) €647  
 Mild AD (total) €17,962  
 Moderate/severe AD (health care) €4659  
 Moderate/severe AD (social care) €34,893  
 Moderate/severe AD (indirect) €820  
 Moderate/severe AD (total) €40,372  
Utilities
 MCI Age 40–49 0.84 [20]
  Age 50–59 0.91 [20]
  Age 60–69 0.90 [20]
  Age 70–79 0.84 [20]
  Age 80–89 0.72 [20]
  Age ≥ 90 0.58 [20]
 Mild AD Mean 0.52 [18]
 Moderate AD Mean 0.21 [18]
 MCI caregiver Mean Depending on age [20]
 Mild AD caregiver Mean 0.71 [18]
 Moderate AD caregiver Mean 0.65 [18]
  1. AD Alzheimer’s disease, OC other causes, MCI mild cognitive impairment, CDR-SB Clinical Dementia Rating-Sum of Boxes, MMSE Mini-Mental State Exam